Concepedia

Daniel M. Schreeder

DM

Statistics

Publications

5

Citations

835

H-Index

5

Active since

2008

Affiliations

University of Alabama at Birmingham(Current)

Daniel M. Schreeder is an author at University of Alabama at Birmingham specializing in life sciences, immunology, and cancer immunology.

Publications per year

2008–2018

5

Publications

5

Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia

Miriam Kim, Kyung–Rok Yu, Saad S. Kenderian et al. · Cell · 2018 · 467 citations · Full text

, , +15

Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement

Douglas B. Johnson, Mellissa J. Nixon, Yu Wang et al. · JCI Insight · 2018 · 159 citations · Full text

, , +17

<scp>FCRL</scp>3 promotes <scp>TLR</scp>9‐induced <scp>B</scp>‐cell activation and suppresses plasma cell differentiation

Fu Jun Li, Daniel M. Schreeder, Ran Li et al. · European Journal of Immunology · 2013 · 83 citations · Full text

, , +16

Cutting Edge: FcR-Like 6 Is an MHC Class II Receptor

Daniel M. Schreeder, John P. Cannon, Jiongru Wu et al. · The Journal of Immunology · 2010 · 70 citations · Full text

, , +14

FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B‐cell chronic lymphocytic leukemia

Daniel M. Schreeder, Jicun Pan, Fu Jun Li et al. · European Journal of Immunology · 2008 · 56 citations · Full text

, , +12

1–5 of 5